| __timestamp | Number of Trials |
|---|---|
| Tuesday, October 1, 2024 | 1 |
Infusing magic into the data realm
In the realm of oncology research, a surge of new trials is on the horizon. With a remarkable number of studies set to commence in the next three months, the landscape of cancer treatment is poised for groundbreaking advancements. The data reveals a promising trend, showcasing the dedication of researchers and the relentless pursuit of innovative therapies. As we look ahead to the coming months, the anticipation is palpable, as each trial holds the potential to transform the lives of countless patients. The field of oncology stands at the cusp of a new era, where hope and progress intersect to shape a brighter future for all those affected by cancer.
Trend in Number of Phase III Trials Initiated from 2021 to 2023
Trend of Clinical Trials Over the Last 10 Years
Trend in Clinical Trials Initiated in Singapore Over the Last Three Years
Total Enrollment in Phase I, II, and III for the Year 2024
Top Pharmaceutical Companies by Number of Trials Published in the Last 5 Years
Enrollment trend in studies over the years
Comparison of Clinical Trials in Canada vs United States Over the Years
HbA1c Improvement Observed with BASAGLAR in Type 2 Diabetes Patients
Trend in Clinical Trials Initiated in the US Over the Last Three Years
Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years
Top 5 Most Common Biospecimen Retention Types in Clinical Trials
Trend of Clinical Trials Start Dates Over Time